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Abstract
South Africa has the highest tuberculosis (TB) disease incidence rate in the world, and TB is
the leading infectious cause of death. Decisions on, and funding for, TB prevention and care
policies are decentralised to the provincial governments and therefore, tools to inform policy
need to operate at this level. We describe the use of a mathematical model planning tool at
provincial level in a high HIV and TB burden country, to estimate the impact on TB burden of
achieving the 90-(90)-90 targets of the Stop TB Partnership Global Plan to End TB. “TIME
Impact” is a freely available, user-friendly TB modelling tool. In collaboration with provincial
TB programme staff, and the South African National TB Programme, models for three (of
nine) provinces were calibrated to TB notifications, incidence, and screening data. Reported
levels of TB programme activities were used as baseline inputs into the models, which were
used to estimate the impact of scale-up of interventions focusing on screening, linkage to
care and treatment success. All baseline models predicted a trend of decreasing TB inci-
dence and mortality, consistent with recent data from South Africa. The projected impacts of
the interventions differed by province and were greatly influenced by assumed current cov-
erage levels. The absence of provincial TB burden estimates and uncertainty in current
activity coverage levels were key data gaps. A user-friendly modelling tool allows TB burden
and intervention impact projection at the sub-national level. Key sub-national data gaps
should be addressed to improve the quality of sub-national model predictions.
Introduction
South Africa has the highest tuberculosis (TB) incidence rate in the world [1], and the disease
is the leading cause of death [2]. The estimated burden of disease differs significantly between
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provinces with the rate of microbiologically confirmed TB (in 2012) ranging from approxi-
mately 400/100,000/year in Limpopo Province to almost 1,200/100,000/year in KwaZulu-Natal
[3]. In addition, the drivers of the epidemic also differ between provinces due to variation in
factors including HIV prevalence, levels of drug resistance, and the capacity of the health sys-
tem to identify and treat TB [4, 5].
Recent modelling studies have shown that scaling up existing interventions in all of South
Africa has the potential to greatly reduce TB incidence and mortality, and to be cost-effective
[6–8]. However, the vast majority of modelling studies have focussed on the national level and
have not addressed potential differences between provinces [6, 7, 9–12].
Evidence-based TB prevention and treatment strategies are agreed upon nationally and
implemented by the provinces. The allocation of budgets to specific activities also takes place
primarily at the provincial level. Provincial TB programmes are resource limited and often
have to make decisions without information on the likely impact of different intervention
options in their setting. With the introduction of additional ring-fenced TB funding (TB con-
ditional grant) in 2017 [13], the availability of an additional sub-national planning tool to proj-
ect impact is highly desirable.
In this article we describe the application of TIME (Tuberculosis Impact Module and Esti-
mates), a user friendly TB transmission model at sub-national level in South Africa. We used
the model to estimate the impact on TB incidence and mortality from 2017 to 2035 of scale-up
of TB screening, linkage and retention interventions to achieve the 90-(90)-90 TB targets of
the Stop TB Partnership Global Plan to End TB [14]. This work was conducted as part of the
South African National TB Think Tank [15].
Methods
TIME model
This work used the TIME module of the Spectrum suite (Version 5�54 Beta 3) [16, 17]. The
TIME model is a user friendly, age-structured, dynamic, compartmental transmission model
of TB. The model includes three disease states: susceptible, latent infection, and active disease.
The model is stratified by TB treatment history, smear status, multidrug resistant TB
(MDR-TB) status and HIV. Smear-negative cases are assumed to be less infectious than those
with smear-positive TB by a factor of 0.22 [18]. The MDR-TB strata represents those with
multi-drug resistant and rifampicin resistant TB, consistent with the reporting of these cases
by WHO as a single group. The HIV positive population is stratified by CD4 count and time
on ART. ART is assumed to reduce the risk of developing TB and the risk of HIV and TB asso-
ciated mortality. As a component of Spectrum, TIME Impact automatically incorporates coun-
try data on TB (notifications, incidence estimates, mortality estimates etc.) from the Global TB
Programme (GTB) at the World Health Organization, HIV estimates (HIV incidence and
prevalence, ART coverage, ART eligibility thresholds) from the Aids Impact Model (AIM, a
module of Spectrum) and demographic projections from DemProj (the demographic module
in Spectrum). A full description of the TIME model can be found in the supplementary mate-
rial of Houben et al.[16]
TIME can be applied at sub-national level using local data. For this work, each province in
South Africa was considered a separate unit assuming no mixing or migration between prov-
inces. The models used provincial level AIM and demographic files supplied by UNAIDS.
Use of the model requires the user to provide input data reflecting current levels of TB con-
trol, including rates of screening, treatment outcomes and sensitivity and specificity of the
diagnostic algorithm. Where possible we used values based on data reported and collated by
the provincial TB programmes. These are described in more detail below.
Mathematical modelling of tuberculosis in South African provinces
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Province selection
TB burden varies across each of the nine provinces of South Africa and is influenced by
numerous demographic and epidemiological factors. KwaZulu-Natal (KZN), Limpopo (LP)
and Western Cape (WC) provinces were selected for this modelling study to illustrate variation
in key epidemiological factors, population size, TB burden, HIV prevalence, ART coverage
and, TB treatment success (Table 1).
Data sources
Burden estimates. Provincial notification data were obtained from national electronic TB
register (ETR.net) reports. Provincial TB incidence was estimated using national TB notifica-
tion data and the national TB incidence estimate from the WHO TB global report to derive a
national case detection ratio (CDR), the proportion of incident TB cases that are notified to
the TB programme [1]. In the absence of provincial-level CDR estimates, the national CDR
was applied to the provincial notification data (assuming the CDR was the same in all prov-
inces) to obtain an estimate of provincial TB incidence. While this is an obvious simplification,
we chose to use this approach rather than introduce other assumptions into the model. TB
mortality was derived using national vital registration (VR) data in combination with WHO
mortality estimates to calculate the percentage of estimated deaths captured by VR systems [1,
19]. This percentage was applied to the province VR data to obtain approximate provincial
mortality estimates [19].
Programme performance. TB treatment outcomes data were obtained from national
electronic TB register (ETR.net) reports. TB screening and testing data was derived from dis-
trict health information system (DHIS) quarterly reports. Nationally, pre-treatment initial loss
to follow-up (ILTFU, the proportion of those diagnosed with TB who did not start treatment)
has been estimated at 17% [20, 21]. The Health Systems Trust (HST) estimates of loss to fol-
low-up were available at provincial level [19]. However, these were defined as the proportion
of new smear-positive patients who did not start treatment or whose treatment was inter-
rupted for two or more months. To derive province level estimates for pre-treatment ILTFU
among all TB cases we used the ratio of the provincial to national HST estimates to adjust the
national ILTFU estimate of 17%. The baseline levels of these TB programmatic activities are
shown in Table 2.
Table 1. Demographic and epidemiological characteristics of the selected provinces. Classifications of “High”, “Medium”, “Low” are relative to national values for
South Africa.
Indicator (year) KwaZulu-Natal (KZN) Limpopo (LP) Western Cape (WC)
Population size (2015) Large
10,919,100
Medium
5,726,800
Medium
6,200,100
TB notification rate (2015) High
671/100,000
Low
297/100,000
High
687/100,000
Total MDR-TB notifications (2015) High
3,763
(34/100,000)
Low
490
(8.6/100,000)
Medium
1,750
(28/100,000)
HIV prevalence (2016) High
18%
Low
8%
Low
7%
ART coverage (2015) High
55%
Medium
46%
Medium
48%
Drug-sensitive TB treatment success [as proxy for programme performance] (2014) Below average (falling)
76.8%
Below average (increasing)
64.9%
Above average (stable)
81.9%
https://doi.org/10.1371/journal.pone.0209320.t001
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While there is considerable uncertainty in the province level data, in particular screening
numbers, we aimed to use data as reported by the provinces where possible. This allowed us to
explore which input data were the key drivers of model projections and where efforts should
be focussed on improving collection and reporting of data to allow better model estimates of
intervention impact. To minimise the effect of misreporting of screening data we used data
from subsequent steps in the diagnostic cascade (numbers of patients with symptoms, num-
bers tested for TB, etc.) to estimate province level values for the specificity and linkage to test-
ing post screening.
Three regional modelling workshops took place in June 2016 which were attended by mem-
bers of provincial TB departments. These workshops built on two previously held national
workshops in which the TIME modelling tool was showcased to the National TB Programme
(NTP). In the regional workshops, draft versions of the provincial models were presented and
attendees were provided the opportunity to work directly with the TIME model and discuss the
available data and model assumptions. While the workshops did not follow a formal elicitation
approach (e.g. Delphi Process) province TB data managers provided input and expert opinion
on the quality, accuracy and representativeness of their local data, and identified important data
gaps to address in the future. The draft models were updated based on these discussions.
Baseline scenario
The baseline model scenario represented the historic, current and projected burden assuming
no future increase in TB and HIV care in South Africa with the exception of antiretroviral
therapy (ART) coverage which was assumed to increase to 90% of all known HIV infected
individuals by 2017 in line with the UNAIDS 90-90-90 targets. Historical values for program-
matic TB parameters were based on the earliest year for which routine data were available and
we assumed that all existing activities continue at their current levels until 2035. The current
value of TB treatment success was calculated as the average of the last five year’s data to
account for large annual fluctuations. Screening, diagnosis, and initiation of treatment were
not modelled explicitly but were simplified based on the diagnostic algorithm from the
National TB Treatment guidelines [22]. Full details of the assumptions and parameter values
can be found in the S1 File.
Model calibration
Each provincial model was fitted to the number of notified TB cases, estimated TB incidence
for the years 2002 to 2015 [1], and notified MDR-TB cases from 2013 to 2015 (Personal
Table 2. Summary of modelled intervention scenarios showing baseline coverage and target values, by province. KZN = KwaZulu-Natal, LP = Limpopo and
WC = Western Cape.
KZN LP WC
Intervention 1: Clinic visiting headcount screened for TB (%) Baseline (2015) 24�4 70 10�4
Intervention (2021) 90 90 90
Intervention 2: ILTFU (%) Baseline (2015) 12�5 14�2 26�9
Intervention (2021) 2�5 2�8 5�4
Intervention 3: DS-TB treatment success (%) Baseline (2015) 76�8 64�9 81�9
Intervention (2021) 85 85 85
DR-TB treatment success (%)
Baseline (2015)� 50 50 50
Intervention (2021) 67 67 67
�DR-TB treatment success is assumed to be the same in each province and is based on national data.
https://doi.org/10.1371/journal.pone.0209320.t002
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Communication, Provincial TB managers, March 2016). There has been a large increase in TB
screening in the last few years so the models were also fitted to TB screening data from 2013 to
2015 (Personal Communication, Provincial TB managers, March 2016). The model was manu-
ally calibrated by adjusting the screening rate, the effective contact rate and the relative rate of
presentation of healthy individuals for screening (compared to those with TB).
Interventions
In line with the 90-(90)-90 targets from the Stop TB Partnership’s Global Plan to End TB [14],
three TB prevention and care interventions were modelled as part of this exercise. Fig 1 shows
the TB care pathway indicating which part of the pathway the interventions target as well as
the baseline values for the key indicator of each of the interventions. The primary aim of these
interventions was to find TB cases (intervention #1), link them to care (intervention #2) and
ensure successful treatment (intervention #3).
Intervention #1 modelled an increase in the proportion of primary health clinic attendees
screened for TB. We assumed screening was based on cough triage, a shortened version of the
WHO screening algorithm consisting of a single question which asks patients whether they
have a cough for more than two weeks (or of any duration if they are known to be HIV-posi-
tive). Intervention #2 modelled an improved linkage to care for those diagnosed with TB. We
assumed ILTFU was reduced by 80% by 2021 compared to baseline values. Intervention #3
assumed increased treatment success rates for drug-susceptible TB (to 85%) and drug-resistant
TB (to 67%), based on the standard six and 24 month regimens respectively.
Linear scale-up from 2016 to 2021 was assumed for all interventions. The target values for
scale-up were determined following detailed discussions with representatives of the NTP and
scientific experts (Table 2). All interventions were assumed to remain at their target levels
from 2021 to 2035.
Results
Engagement with sub-national TB programme staff
A series of three regional workshops were held which involved the provincial TB managers
and their teams as part of the sub-national modelling process. Attendees gained hands-on
experience of using the modelling planning tool and the workshop activities illustrated the
Fig 1. TB care pathway. The key steps in the care pathway (from active disease to successful treatment) are
represented by the white boxes. Grey boxes indicate the steps on the pathway targeted by each of the interventions and
the baseline values used in the model. KZN = KwaZulu-Natal, LP = Limpopo and WC = Western Cape.
https://doi.org/10.1371/journal.pone.0209320.g001
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relationship between quality data as model inputs and how variability can greatly influence the
outputs and predicted impact.
Baseline fit and projection
Fig 2 shows the baseline fit of TB notifications and incidence for the three provincial models.
The model outputs match the observed trends in TB notifications in all three provinces (Fig
2B, 2D and 2F). The TB incidence model outputs fall within the uncertainty range of the esti-
mated incidence for all three provinces (Fig 2A, 2C and 2E). The models suggest that the
Fig 2. Baseline plots of TB notifications (number) and TB incidence (/100,000) for each province. KZN = KwaZulu-Natal, LP = Limpopo and
WC = Western Cape. (Markers = provincial estimates derived from WHO data with plausible range; line = model).
https://doi.org/10.1371/journal.pone.0209320.g002
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incidence peaked in 2006 for KwaZulu-Natal (Fig 2A) and Limpopo (Fig 2C) while in Western
Cape the peak was earlier in 2003 (Fig 2E).
Following their peaks, all three models show a trend of decreasing incidence until 2019 fol-
lowed by gradual decline until 2035, although the decline in Western Cape is smaller than
those predicted for KwaZulu-Natal and Limpopo. Under the baseline scenario from 2015 to
2035, the models suggest that the TB incidence will decrease by 46%, 49% and 22% for Kwa-
Zulu-Natal, Limpopo, and Western Cape respectively (Fig 2A, 2C and 2E). Similarly, the TB
mortality is predicted to decrease by 58%, 63% and 26% for KwaZulu-Natal, Limpopo, and
Western Cape respectively (Fig B in S1 File).
Intervention impact
Fig 3 shows the percentage reduction in the incidence and mortality rates in 2035 compared to
baseline for each of the intervention scenarios. As expected, the combination of all three inter-
ventions was predicted to result in the largest reductions in TB incidence and mortality in all
three provinces (Fig 3A and 3B, rightmost bars).
In KwaZulu-Natal, Fig 3A shows that increased TB screening (intervention #1) was pro-
jected to have the greatest impact on incidence with an 11�5% reduction with improved linkage
into care (interventions #2) and increased treatment success (intervention #3) having less than
half the impact (4�9% and 5�6% respectively).
A similar pattern was observed in Western Cape where intervention #1 had the biggest
impact on incidence with a reduction of 25.0%, while interventions #2 and #3 showed smaller
reductions (13�8% and 4�6% respectively).
In contrast, in Limpopo improved treatment success (intervention #3) was projected to
have the largest reduction in incidence (11�5%) compared to intervention #2 (5�2%) and inter-
vention #1 (3�4%) (Fig 3A).
The impact of the interventions on TB mortality showed similar patterns to those seen for
the impact on incidence, although the percentage impact was greater for all interventions in all
three provinces (Fig 3B).
Discussion
All models predicted a continuing trend of decreasing TB incidence and mortality, consistent
with the recent observed decrease in TB notifications in South Africa. The projected impacts
of the interventions differed by province and appear to be mainly driven by differences in cur-
rent reported coverage levels rather than differences in the underlying epidemiology. The
absence of sub-national TB burden estimates and uncertainty in current activity coverage lev-
els are important data gaps that should be addressed at the provincial level.
The regional workshops and involvement of the provincial TB managers and their teams
were critical components of the sub-national modelling process. They provided an opportu-
nity for staff from the provincial TB programmes to have first-hand experience of the model-
ling planning tool and offered insights into the workings and requirements of the modelling
process. This fostered an understanding of the importance of good quality data and how
changes in model inputs can greatly influence the outputs and predicted impact of what is
being modelled. The process also highlighted to programme staff areas where strengthening
data collection could improve future decision making.
The TIME model has been used previously to assess the TB epidemic in South Africa [6–8],
but this was the first instance of the model being used at the sub-national level in South Africa.
The previous work [6] suggested that at a national level, the greatest impact could be achieved
by scaling up screening of primary health clinic attendees. In contrast, our sub-national
Mathematical modelling of tuberculosis in South African provinces
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analysis suggests screening would only be the most effective strategy in 2 of the 3 provinces
studied. The contrasting impact of the interventions in the provinces reflects that the TB epi-
demic in South Africa differs by province and that the responses need to take into account the
provincial epidemiological context. They also highlight an important role for the use of sub-
national planning tools.
Several studies have used modelling to look at the TB epidemic in South Africa and assess
the impact of TB prevention and care interventions [6, 9–12]. These studies used different
models to assess the impact of different aspects of TB prevention and care interventions cover-
ing various time periods for their predictions, ranging from ten to 38 years. However, none of
Fig 3. Projected percentage reduction in incidence and mortality rate in 2035, compared to the baseline scenario, by province and
intervention. KZN = KwaZulu-Natal, LP = Limpopo and WC = Western Cape.
https://doi.org/10.1371/journal.pone.0209320.g003
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these analyses aimed to inform policy at the subnational level. Several modelling studies have
looked at the TB epidemic at sub-national level in South Africa [23, 24]. Gilbert et al. [23]
looked at the impact of combinations of TB interventions over a ten-year period but the analy-
sis was confined to the rural setting of Msinga sub-district in KwaZulu-Natal. Another group
modelled the TB epidemic in the urban setting of the city of Cape Town in Western Cape
which was underpinned by access to high quality TB notification and programmatic data [24].
While these models were able to characterise the epidemic in a single setting they did not com-
pare the effect of interventions across provinces using the same modelling framework.
This analysis suggested that the scale-up of key interventions had the potential to signifi-
cantly reduce TB incidence and mortality in all three provinces. The impact of the interven-
tions was greatly affected by the baseline levels of the core activities of each intervention.
Increasing coverage of TB screening (intervention #1) was predicted to have a substantial
impact on incidence and mortality in Western Cape and KwaZulu-Natal compared to a very
modest effect in Limpopo as the reported baseline coverage of Limpopo’s TB screening was
already high and close to the target value. Achieving the 90% screening target in Limpopo
required an increase of 29% in coverage levels compared to Western Cape where the TB
screening coverage had to increase almost nine-fold in order to reach target levels. This sug-
gested that very different levels of resources may be required to achieve the targets in different
settings.
Several of the key parameters used in the models were not available at the provincial level
and had to be calculated from various data sources which were of variable quality and com-
pleteness. This included national estimates of incidence and mortality which were themselves
based on modelled data. The use of assumptions to derive provincial-level data resulted in esti-
mates with great uncertainty which might not have reflected the reality on the ground. Certain
estimates were derived assuming that parameter values were the same across provinces which
may have masked the heterogeneity in the epidemiology and intervention coverage at provin-
cial level. The greater scrutiny that was applied to TB data allowed gaps in quality and report-
ing to be highlighted. The routine programmatic data used to parameterise the models may
have been of variable quality and completeness which varied by province. The models did not
provide granular control over the TB care pathway and algorithms, resulting in crude esti-
mates of what is in reality a complex process.
The TIME model includes the effect of HIV on TB but does not currently include other
known risk factors for TB such as diabetes or smoking. Strategies to detect and prevent TB in
these risk groups may form an important part of future efforts to control TB in South Africa.
Future work could consider differences in the prevalence of diabetes and other risk factors
between provinces when assessing the likely impact of strategies focussed on these risks
groups. The scale-up of interventions illustrated the possible impact but did not provide spe-
cific details of how they could be implemented. These models were not meant to offer defini-
tive estimates of future disease burden or intervention impact but instead to illustrate the
effect of prioritising different components of TB prevention and care. In addition, we did not
consider the resource or financial implications of scaling up these interventions in each prov-
ince. Analysis of the costs and cost-effectiveness of different strategies at the province level will
provide further evidence on which to base the sub-national planning of TB control activities.
This is the focus on ongoing research by our group, incorporating province level impact esti-
mates and differences in service costs at the subnational level.
Ideally, the choice of how best to prioritise TB prevention and care activities within prov-
inces should take into consideration the current levels of TB activities in order to assess where
gaps exist. These choices rely on the reporting of high quality and accurate TB data, both on
disease burden and programme performance. Incorrect reporting could result in focus being
Mathematical modelling of tuberculosis in South African provinces
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given to activities which may not offer much additional benefit in relation to the resources
required to implement them. The use of provincial data and modelling provides insight into
the provincial TB epidemics allowing for more attention to be given to the local level context
where decisions are best taken on how to tackle the TB epidemic. To ensure the results of these
and similar analyses can inform future TB programme efforts it is essential that long-term
links are established and maintained between, policy makers, provincial TB programme staff
and those generating research evidence. The success of the national TB think tank [15] illus-
trates the potential for such collaboration.
A user-friendly modelling tool allows burden and intervention impact projection at the
sub-national level. Key sub-national data gaps should be addressed to improve the quality of
sub-national model predictions.
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